SCHEMBL762583

SCHEMBL762583

Cc1cnc(C)c(N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28300406 1.00 NOS3 (0.52)
SCHEMBL3943201 0.79
SCHEMBL172774 0.79
SCHEMBL10305656 0.77
SCHEMBL845972 0.75
SCHEMBL221321 0.75
SCHEMBL18900279 0.75
SCHEMBL22576156 0.75
SCHEMBL305800 0.75
SCHEMBL29813523 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110845400-A Synthetic method of 2, 5-dimethyl-3-bromopyridine 常州传侑环保科技有限公司 2020-02-28 CN claimed
CN-109748858-A A kind of synthetic method of 2,5- dimethyl -3- bromopyridine 丹阳市易通安全技术服务有限公司 2019-05-14 CN claimed
CN-107089939-A A kind of synthetic method of the bromopyridine of 2,5 dimethyl 3 刘瑞海 2017-08-25 CN claimed
EP-4722211-A1 FGFR2/3 SELECTIVE INHIBITOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2026-04-08 EP disclosed
US-20260078122-A1 INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2026-03-19 US disclosed
EP-4673436-A1 INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2026-01-07 EP disclosed
WO-2025106949-A1 WRN INHIBITORS RADD PHARMACEUTICALS, INC. (US) 2025-05-22 WO disclosed
WO-2025052129-A1 PYRIDINE DERIVATIVES WHICH ACT AS INHIBITORS OF MPTP. NRG THERAPEUTICS LTD (GB) 2025-03-13 WO disclosed
US-20250042890-A1 METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOF INSILICO MEDICINE IP LIMITED (HK) 2025-02-06 US disclosed
US-20240398776-A1 INHIBITORS OF TGF-BETA R1 (ALK5) USEFUL TO TREAT CELL PROLIFERATION DISORDERS NEXYS THERAPEUTICS, INC. (US) 2024-12-05 US disclosed
WO-2024240231-A1 FGFR2/3 SELECTIVE INHIBITOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF 长春金赛药业有限责任公司 2024-11-28 WO disclosed
EP-0927161-B1 SUBSTITUTED CYCLIC AMINE METALLOPROTEASE INHIBITORS PROCTER & GAMBLE (US) 2002-10-16 EP disclosed
US-6417219-B1 ENZYME INHIBITORS AND OSTEOARTHRITIS THE PROCTOR & GAMBLE COMPANY 2002-07-09 US disclosed
US-20020072517-A1 Substituted cyclic amine metalloprotease inhibitors THE PROCTER & GAMBLE COMPANY 2002-06-13 US disclosed
US-20020061877-A1 Substituted cyclic amine metalloprotease inhibitors THE PROCTER & GAMBLE COMPANY 2002-05-23 US disclosed
EP-0927161-A1 SUBSTITUTED CYCLIC AMINE METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-07-07 EP disclosed
WO-1998008815-A1 SUBSTITUTED CYCLIC AMINE METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1998-03-05 WO disclosed
EP-0220204-A1 THERMOSETTABLE POLYSTYRYLPYRIDINE PREPOLYMER TERMINATED WITH ETHYLENICALLY UNSATURATED GROUPS AND CURED PRODUCTS THEREFROM THE DOW CHEMICAL COMPANY (US) 1987-05-06 EP disclosed
WO-1986006386-A1 THERMOSETTABLE POLYSTYRYLPYRIDINE PREPOLYMER TERMINATED WITH ETHYLENICALLY UNSATURATED GROUPS AND CURED PRODUCTS THEREFROM THE DOW CHEMICAL COMPANY (US) 1986-11-06 WO disclosed
US-4575542-A Thermosettable polystyrylpyridine prepolymer terminated with ethylenically unsaturated groups and cured products therefrom THE DOW CHEMICAL COMPANY (US) 1986-03-11 US disclosed